Coreg. Buy more. Save more.

The Food and Drug Administration has approved a new application for Coreg CR (carvedilol phosphate) extended-release capsules for the treatment of mild to severe heart failure, the reduction of cardiovascular mortality in patients who have survived the acute phase of myocardial infarction, and hypertension.

Related Results

Trial data added to coreg labelFlamel Technologies Welcomes FDA Approval of COREG CR™Fla…